368 related articles for article (PubMed ID: 7529060)
1. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.
Murray L; Chen B; Galy A; Chen S; Tushinski R; Uchida N; Negrin R; Tricot G; Jagannath S; Vesole D
Blood; 1995 Jan; 85(2):368-78. PubMed ID: 7529060
[TBL] [Abstract][Full Text] [Related]
2. Analysis of human hematopoietic stem cell populations.
Murray L; DiGiusto D; Chen B; Chen S; Combs J; Conti A; Galy A; Negrin R; Tricot G; Tsukamoto A
Blood Cells; 1994; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
[TBL] [Abstract][Full Text] [Related]
3. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
Van den Berg D; Wessman M; Murray L; Tong J; Chen B; Chen S; Simonetti D; King J; Yamasaki G; DiGiusto R; Gearing D; Reading C
Blood; 1996 May; 87(10):4348-57. PubMed ID: 8639795
[TBL] [Abstract][Full Text] [Related]
4. Biological characterization of stem cell present in mobilized peripheral blood of CML patients.
Tsukamoto AS; Reading C; Carella A; Frassoni F; Gorin C; LaPorte J; Negrin R; Blume K; Cunningham I; Deisseroth A
Bone Marrow Transplant; 1994; 14 Suppl 3():S25-32. PubMed ID: 7535151
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
[TBL] [Abstract][Full Text] [Related]
6. Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft.
Fraser CC; Kaneshima H; Hansteen G; Kilpatrick M; Hoffman R; Chen BP
Blood; 1995 Sep; 86(5):1680-93. PubMed ID: 7655000
[TBL] [Abstract][Full Text] [Related]
7. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities.
Uchida N; Combs J; Chen S; Zanjani E; Hoffman R; Tsukamoto A
Blood; 1996 Aug; 88(4):1297-305. PubMed ID: 8695847
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.
Hess DA; Levac KD; Karanu FN; Rosu-Myles M; White MJ; Gallacher L; Murdoch B; Keeney M; Ottowski P; Foley R; Chin-Yee I; Bhatia M
Blood; 2002 Aug; 100(3):869-78. PubMed ID: 12130497
[TBL] [Abstract][Full Text] [Related]
9. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
Young JC; Lin K; Hansteen G; Travis M; Murray LJ; Jaing L; Scollay R; Hill BL
Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic potential and retroviral transduction of CD34+ Thy-1+ peripheral blood stem cells from asymptomatic human immunodeficiency virus type-1-infected individuals mobilized with granulocyte colony-stimulating factor.
Junker U; Moon JJ; Kalfoglou CS; Sniecinski I; Forman SJ; Zaia JA; Kaneshima H; Böhnlein E
Blood; 1997 Jun; 89(12):4299-306. PubMed ID: 9192752
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone.
Luens KM; Travis MA; Chen BP; Hill BL; Scollay R; Murray LJ
Blood; 1998 Feb; 91(4):1206-15. PubMed ID: 9454750
[TBL] [Abstract][Full Text] [Related]
12. CD34+Thy-1+Lin- stem cells from mobilized peripheral blood.
Murray LJ; Tsukamoto A; Hoffman R
Leuk Lymphoma; 1996 Jun; 22(1-2):37-42, follow. 186, color plate I. PubMed ID: 8724526
[TBL] [Abstract][Full Text] [Related]
13. Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice.
Chen BP; Galy A; Kyoizumi S; Namikawa R; Scarborough J; Webb S; Ford B; Cen DZ; Chen SC
Blood; 1994 Oct; 84(8):2497-505. PubMed ID: 7522631
[TBL] [Abstract][Full Text] [Related]
14. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
15. CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells.
Murray LJ; Bruno E; Uchida N; Hoffman R; Nayar R; Yeo EL; Schuh AC; Sutherland DR
Exp Hematol; 1999 Aug; 27(8):1282-94. PubMed ID: 10428505
[TBL] [Abstract][Full Text] [Related]
16. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells.
Haas R; Möhle R; Pförsich M; Fruehauf S; Witt B; Goldschmidt H; Hunstein W
Blood; 1995 Apr; 85(7):1936-43. PubMed ID: 7535595
[TBL] [Abstract][Full Text] [Related]
17. The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis.
Goan SR; Fichtner I; Just U; Karawajew L; Schultze W; Krause KP; von Harsdorf S; von Schilling C; Herrmann F
Blood; 1995 Jul; 86(1):89-100. PubMed ID: 7540891
[TBL] [Abstract][Full Text] [Related]
18. Identification of CD34+ subsets after glycoprotease selection: engraftment of CD34+Thy-1+Lin- stem cells in fetal sheep.
Sutherland DR; Yeo EL; Stewart AK; Nayar R; DiGiusto R; Zanjani E; Hoffman R; Murray LJ
Exp Hematol; 1996 Jun; 24(7):795-806. PubMed ID: 8647230
[TBL] [Abstract][Full Text] [Related]
19. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens.
Bender JG; Lum L; Unverzagt KL; Lee W; Van Epps D; George S; Coon J; Ghalie R; McLeod B; Kaizer H
Bone Marrow Transplant; 1994 Apr; 13(4):479-85. PubMed ID: 7517260
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
